✦ LIBER ✦

Toremifene for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer: phase II results and phase III design

✍ Scribed by E. Harrison; M. Steiner; K.G. Barnette

Book ID: 116945235
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 53 KB
Volume: 66
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2005.06.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-1.08: Multicenter Phase III Randomize

MP-1.08: Multicenter Phase III Randomized Controlled Trial of Toremifene to Prevent Fractures and Other Adverse Effects of Androgen Deprivation Therapy in Men with Prostate Cancer

✍ M. Steiner; G. Barnette; M. Hancock; R. Morton; D. Rodriguez 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Toremifene Increases Bone Mineral Densit

Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study

✍ Smith, M.R.; Malkowicz, S.B.; Chu, F.; Forrest, J.; Price, D.; Sieber, P.; Barne 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 93 KB

Concurrent and adjuvant docetaxel with t

Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial

✍ Michel Bolla; Jean Michel Hannoun-Levi; Jean-Marc Ferrero; Philippe Maingon; Joë 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Effects of androgen deprivation therapy

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series

✍ Morrissey, Colm; Roudier, Martine P; Dowell, Alex; True, Lawrence D; Ketchanji, 📂 Article 📅 2013 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 516 KB

Multicenter phase 2 study of neoadjuvant

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer : Results of Cancer and Leukemia Group B 99811

✍ William Kevin Kelly; Susan Halabi; Aymen Elfiky; San-San Ou; Jeff Bogart; Michae 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Long-term changes in bone mineral densit

Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values

✍ Vivek K. Wadhwa; Robin Weston; Rahul Mistry; Nigel J. Parr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB